Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Oncology Letters|November 2, 2020
ROS1 rearrangements are uncommon in biliary tract cancersFrancesca Mazzoni, Paolo Petreni, Enrico Vasile, et al.
Oncology Research|April 3, 2026
Serum Biomarkers in Bladder Cancer: NMR Metabolomics for Identification and Monitoring during Platinum-Based TherapyRoberta Giorgione, Daniela Grasso, Elisabetta Gambale, et al.
Frontiers in Oncology|December 1, 2022
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life populationSara Fancelli, Enrico Caliman, Francesca Mazzoni, et al.
The Oncologist|January 22, 2026
Everolimus as maintenance therapy in advanced neuroendocrine neoplasms: Results from the MAVERIC Phase II Trial (1499 WORDS MAIN TEXT)Lorenzo Antonuzzo, Daniele Lavacchi, Francesca Spada, et al.
In Vivo (Athens, Greece)|October 30, 2025
A Snapshot from the Italian Clinical Practice Regarding Efficacy and Utility Rate of Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: The RealBLADDER StudyElisabetta Gambale, Roberta Giorgione, Umberto Basso, et al.
Science Signaling|April 6, 2017
The conformational state of hERG1 channels determines integrin association, downstream signaling, and cancer progressionAndrea Becchetti, Silvia Crescioli, Francesca Zanieri, et al.
Scientific Reports|June 19, 2026
Clinical and pathological predictors of early recurrence after neoadjuvant cisplatin gemcitabine in muscle invasive bladder cancer in the RealBLADDER studyGiandomenico Roviello, Elisabetta Gambale, Roberta Giorgione, et al.
BMC Cancer|October 9, 2021
Results of the observational prospective RealFLOT studyElisa Giommoni, Daniele Lavacchi, Giuseppe Tirino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2014
hERG1 channels regulate VEGF-A secretion in human gastric cancer: clinicopathological correlations and therapeutical implicationsOlivia Crociani, Elena Lastraioli, Luca Boni, et al.
The Oncologist|November 20, 2025
Real-world effectiveness of Avelumab maintenance in advanced urothelial carcinoma: results from the Italian multicenter MALVA study (Meet-URO 25)Giandomenico Roviello, Elisabetta Gambale, Irene De Gennaro Aquino, et al.
Pageof 12